Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference38 articles.
1. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations;Salani;Am. J. Obstet. Gynecol.,2011
2. Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics;Modesitt;Expert. Opin. Pharmacother.,2007
3. Optimal chemotherapy treatment for women with recurrent ovarian cancer;Fung-Kee-Fung;Curr. Oncol.,2007
4. Bevacizumab combined with weekly paclitaxel, Pegylated liposomal doxorubicin, or Topotecan in platinum-resistant recurrent ovarian cancer: analysis by chemotherapy cohort of the randomized phase III AURELIA trial;Poveda;J. Clin. Oncol.,2015
5. Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 2.2015;NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®),2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance;Biochemical Pharmacology;2024-03
2. Exploring patient medication adherence and data mining methods in clinical big data: A contemporary review;Journal of Evidence-Based Medicine;2023-09
3. Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity;Gene;2023-08
4. PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1;MedComm;2023-03-28
5. Đánh giá thời gian sống thêm toàn bộ của bệnh nhân ung thư biểu mô buồng trứng tái phát được hóa trị phác đồ liposomal doxorubicin - carboplatin tại Bệnh viện K;Journal of Clinical Medicine- Hue Central Hospital;2022-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3